Akzo Nobel names the price for Organon
This article was originally published in Clinica
Executive Summary
Akzo Nobel and bioMerieux have reached a price for the Organon Teknika diagnostics business. The new owners bioMerieux will pay E311 million ($263 million) in cash to acquire the E527 million turnover immunodiagnostic, haemostasis and automated microbiology testing division, based in Boxtel, the Netherlands.